Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| Double-patenting + other | 2 (50%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PERREIRA, MELISSA JEAN | 1 | 52.0% | +25.9% |
| LEWOCZKO, EVAN MICHAEL | 1 | — | — |
| BALDWIN, RANDALL KERN | 1 | 79.3% | +28.0% |
| LADD, CAROLYN LOUISE | 1 | 57.0% | +47.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18340594 | METHODS AND SYSTEMS FOR AUTOMATIC DIFFERENTIATION OF DISCRETE AND DISCRETE-CONTINUOUS STOCHASTIC PROGRAMS | BALDWIN, RANDALL KERN | — |
| 18248124 | USE OF AN ERK INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS | LADD, CAROLYN LOUISE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19548526 | HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | PERREIRA, MELISSA JEAN | — |
| 18340594 | METHODS AND SYSTEMS FOR AUTOMATIC DIFFERENTIATION OF DISCRETE AND DISCRETE-CONTINUOUS STOCHASTIC PROGRAMS | BALDWIN, RANDALL KERN | — |
| 18248124 | USE OF AN ERK INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS | LADD, CAROLYN LOUISE | — |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| 1612 | 1 |
| 2125 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19548526 | HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | PERREIRA, MELISSA JEAN | 1618 | §102§103DP | Non-Final OA | — | Pending | Feb 24, 2026 |
| 18474218 | HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | LEWOCZKO, EVAN MICHAEL | 1612 | §103§112DP | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18340594 | METHODS AND SYSTEMS FOR AUTOMATIC DIFFERENTIATION OF DISCRETE AND DISCRETE-CONTINUOUS STOCHASTIC PROGRAMS | BALDWIN, RANDALL KERN | 2125 | §101§112 | Non-Final OA | — | Pending | Jun 23, 2023 |
| 18248124 | USE OF AN ERK INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS | LADD, CAROLYN LOUISE | 1622 | §102§103 | Non-Final OA | — | Pending | Apr 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial